K.M. Anderson
About
In The Last Decade
K.M. Anderson
40 papers receiving 929 citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 274
- Rehabilitation 138
- Genetics 132
- Immunology 113
- Pharmacology 105
Countries citing papers authored by K.M. Anderson
This map shows the geographic impact of K.M. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.M. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.M. Anderson more than expected).
Fields of papers citing papers by K.M. Anderson
This network shows the impact of papers produced by K.M. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.M. Anderson. The network helps show where K.M. Anderson may publish in the future.
Co-authorship network of co-authors of K.M. Anderson
This figure shows the co-authorship network connecting the top 25 collaborators of K.M. Anderson. A scholar is included among the top collaborators of K.M. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.M. Anderson. K.M. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 22 | |
| 3 | 19 | |
| 4 | 12 | |
| 5 | 114 | |
| 6 | 59 | |
| 7 | 65 | |
| 8 | 43 | |
| 9 | 8 | |
| 10 | NTBN, a free radical spin trap induces programmed cell death in human pancreatic cancer (PANC-1) cells. | 5 |
| 11 | 3 | |
| 12 | 10 | |
| 13 | 15 | |
| 14 | Selecting super service people. | 2 |
| 15 | In vitro and in vivo pharmacologic activities of antisense oligonucleotides. | 62 |
| 16 | 5 | |
| 17 | Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. | 15 |
| 18 | Sequential hormone therapy for advanced breast cancer. | 5 |
| 19 | New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. | 86 |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.